BioSpace News Archive

Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to participate in two upcoming investor conferences.

Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc.

Taiho Oncology Inc. and Astex Pharmaceuticals, Inc. announced today details of studies to be presented at the 65th American Society of Hematology (ASH) Annual Meeting, to be held Dec. 9-12, 2023, in San Diego.

Phase Genomics, Inc., a global innovator for industry-leading genomic solutions, today announced the presentation of new data from the proximity ligation sequencing-based OncoTerra cytogenomics platform on the leading-edge AVITI next-generation sequencing system.

The global process chromatography market size was valued at USD 12.5 billion in 2022 and is projected to surpass around USD 27.87 billion by 2032, expanding at a healthy CAGR of 8.4% from 2023 to 2032.

Owl Therapeutics, a wholly-owned subsidiary of Gryphon Bio, today announced a global licensing and collaboration agreement with Abliva AB of Lund, Sweden, to advance Abliva’s NeuroSTAT® (OWL-1410) for the prevention and treatment of moderate to severe traumatic brain injury (TBI).

Scholar Rock announced that the company granted inducement equity awards covering an aggregate of 13,125 shares of its common stock to one newly hired employee, consisting of inducement stock options to purchase an aggregate of 7,500 shares of common stock and inducement restricted stock units, covering an aggregate of 5,625 shares of its common stock.

Cellectis announced that it will hold a general meeting on December 22, 2023 at 2:30 p.m. CET at the Biopark auditorium, 11 rue Watt, 4th floor, 75013 Paris, France.

Theralase® Technologies Inc. has commenced a non-brokered private placement of units of the Company to raise up to $CAN 1.5 M.

Medtronic plc announced that the United States Food and Drug Administration has approved the Symplicity Spyral™ renal denervation system, also known as the Symplicity™ blood pressure procedure, for the treatment of hypertension.